Ouraring Raises $875M Series E, Valuation Hits $11B

Oura Health Secures $875 Million in Series E Funding

Oura Health Oy, the company responsible for the popular Oura ring focused on health and fitness tracking, is reportedly securing $875 million in a new Series E funding round.

According to a recent Bloomberg report, this financing will value the company at approximately $10.9 billion.

Valuation and Growth

The anticipated closure of this round is slated for the end of the current month. This investment would effectively double Oura’s valuation, which stood at $5 billion following its Series D round announced in December of the previous year.

Sources indicate the Series E round has the potential to surpass $900 million in total investment.

Sales and Revenue Projections

To date, Oura has successfully sold 5.5 million rings. This represents a significant increase compared to the 2.5 million units reported in June 2024.

The company is projected to generate over $1 billion in revenue this year, a doubling of the $500 million earned in 2024.

Looking ahead to 2026, Oura Health forecasts sales exceeding $1.5 billion.

Strategic Use of Funds

The newly acquired funding will be strategically allocated to several key areas.

• Scaling production capabilities to meet growing demand.
• Further expansion into international markets.
• Continued investment in research and product development.

Drivers of Recent Success

Bloomberg highlights several factors contributing to the company’s recent growth trajectory.

These include an increase in purchases by female consumers, strong sales through retail channels, utilization of health savings accounts for purchases, and successful expansion into new international markets.